191 related articles for article (PubMed ID: 21482037)
21. Management of retroperitoneal lymph nodes in advanced ovarian cancer.
Hacker NF; Valmadre S; Robertson G
Int J Gynecol Cancer; 2008; 18 Suppl 1():7-10. PubMed ID: 18336392
[TBL] [Abstract][Full Text] [Related]
22. [The surgical treatment of ovarian cancer].
Burghardt E; Lahousen M; Stettner H
Geburtshilfe Frauenheilkd; 1990 Sep; 50(9):670-7. PubMed ID: 2272432
[TBL] [Abstract][Full Text] [Related]
23. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
24. Lymph node metastasis in stage I epithelial ovarian cancer.
Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
[TBL] [Abstract][Full Text] [Related]
25. [Lymphadenectomy in the treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Dec; 27(6):743-8. PubMed ID: 16447650
[TBL] [Abstract][Full Text] [Related]
26. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
Camara O; Sehouli J
Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
[TBL] [Abstract][Full Text] [Related]
27. Effect of retroperitoneal lymphadenectomy on prognosis of patients with epithelial ovarian cancer.
Wang Z; Xiong Z; Wang S
Chin Med J (Engl); 2003 Apr; 116(4):588-92. PubMed ID: 12875728
[TBL] [Abstract][Full Text] [Related]
28. Advances in treatment of epithelial ovarian cancer.
Kikkawa F; Nawa A; Ino K; Shibata K; Kajiyama H; Nomura S
Nagoya J Med Sci; 2006 Jan; 68(1-2):19-26. PubMed ID: 16579172
[TBL] [Abstract][Full Text] [Related]
29. The clinical significance of occult macroscopically positive retroperitoneal nodes in patients with epithelial ovarian cancer.
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Jul; 82(1):143-9. PubMed ID: 11426976
[TBL] [Abstract][Full Text] [Related]
30. [Lumbo-aortic lymphadenectomy in ovarian cancers].
Bonnier P; Piana L
Ann Chir; 1991; 45(6):450-3; discussion 454-5. PubMed ID: 1929159
[TBL] [Abstract][Full Text] [Related]
31. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
33. Role of lymphadenectomy in ovarian cancer.
Panici PB; Angioli R
Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):529-51. PubMed ID: 12413933
[TBL] [Abstract][Full Text] [Related]
34. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
35. [The role of lymph node dysection in early and advanced stages of ovarian cancer].
Ismail E; Kornovski Y
Akush Ginekol (Sofiia); 2014; 53(8):17-20. PubMed ID: 25672085
[TBL] [Abstract][Full Text] [Related]
36. A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
Deng T; Liu K; Chen L; Chen X; Li HW; Guo H; Zhang H; Xiang L; Feng X; Wang X; Ngan HY; Zhao J; Zou D; Liu Q; Liu J
J Gynecol Oncol; 2023 May; 34(3):e52. PubMed ID: 37116952
[TBL] [Abstract][Full Text] [Related]
37. [A rational selection of retroperitoneal lymphadenectomy for advanced epithelial ovarian cancer].
Wang W; Sun R; Ma L
Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):108-9. PubMed ID: 11263195
[TBL] [Abstract][Full Text] [Related]
38. Maximum effort in the management of ovarian cancer, including pelvic and para-aortic lymphadenectomy.
Allen DG; Planner RS; Grant PT
Aust N Z J Obstet Gynaecol; 1992 Feb; 32(1):50-3. PubMed ID: 1586336
[TBL] [Abstract][Full Text] [Related]
39. The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy.
Signorelli M; Fruscio R; Ceppi L; Dell'anna T; Vitobello D; Chiappa V; Siesto G; Milani R; Landoni F; Mangioni C
Gynecol Oncol; 2014 Feb; 132(2):312-5. PubMed ID: 24423881
[TBL] [Abstract][Full Text] [Related]
40. [An analysis of pelvic and para-aortic lymph node metastasis in ovarian carcinoma by systematic retroperitoneal lymph node dissection].
Tsumura N; Sakuragi N; Hareyama H; Nomura E; Ohkouchi T; Yamamoto R; Takeda N; Nishiya M; Hirahatake K; Fujino T; Okubo H; Satoh C; Makinoda S; Kawaguchi I; Fujimoto S
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jul; 48(7):508-14. PubMed ID: 8754392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]